Literature DB >> 28709383

What is the current level of mental health service delivery and expenditure on infants, children, adolescents, and young people in Australia?

Leonie Segal1, Sophie Guy1, Gareth Furber1.   

Abstract

OBJECTIVES: The study aim was to estimate the current level of ambulatory mental health service delivery to young people aged 0-24 years in Australia and associated government expenditure. Recognising the importance of the early years for the development of mental illness and socioeconomic outcomes, we were particularly interested in service access by infants and young children.
METHODS: We extracted information from government administrative datasets on the number of people who received mental health services, number of services and expenditure through the health sector for 2014-2015. Results are primarily reported by age groups 0-4, 5-11, 12-17 and 18-24 years.
RESULTS: Less than 1% of 0- to 4-year-olds received a mental health service in any one service setting, whereas nearly 11% of 18- to 24-year-olds received a mental health service through the Medicare Benefits Schedule Better Access programme alone. Many more services were delivered to 12- to 24-year-olds (>4 million) than to 0- to 11-year-olds (552,000). Medicare Benefits Schedule Better Access delivers services to more children and youth than do state/territory community mental health services, although the latter provide more services per client. In 2013-2014, Australian Government expenditure on ambulatory mental health services for 0- to 24-year-olds was AUD428 million, similar to the AUD491 million spent by state/territory governments.
CONCLUSION: The study provides a benchmark for data-driven service planning to ensure that the mental health needs of infants, children and young people are met. Our results indicate that the youngest age group are underserviced relative to need, even noting infants and children may receive services for behavioural/mental health issues from providers not captured in our study (such as paediatricians). The developmental origins of mental illness underlies the urgency of adequate provision by governments of perinatal, infant and child mental health services to avoid loss of life potential and reduce the pressures on the justice, child protection and welfare systems.

Entities:  

Keywords:  Mental health services; administrative data; child and adolescent; service use

Mesh:

Year:  2017        PMID: 28709383     DOI: 10.1177/0004867417717796

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  4 in total

1.  Healing The Past By Nurturing The Future: A qualitative systematic review and meta-synthesis of pregnancy, birth and early postpartum experiences and views of parents with a history of childhood maltreatment.

Authors:  Catherine Chamberlain; Naomi Ralph; Stacey Hokke; Yvonne Clark; Graham Gee; Claire Stansfield; Katy Sutcliffe; Stephanie J Brown; Sue Brennan
Journal:  PLoS One       Date:  2019-12-13       Impact factor: 3.240

2.  Reconnecting mothers and children after violence (RECOVER): a feasibility study protocol of child-parent psychotherapy in Australia.

Authors:  Leesa Hooker; Emma Toone; Vibhay Raykar; Cathy Humphreys; Anita Morris; Elizabeth Westrupp; Angela Taft
Journal:  BMJ Open       Date:  2019-05-06       Impact factor: 2.692

3.  The cost of Medicare-funded medical and pharmaceutical services for mental disorders in children and adolescents in Australia.

Authors:  Long Khanh-Dao Le; Sophy Shih; Scott Richards-Jones; Mary Lou Chatterton; Lidia Engel; Christopher Stevenson; David Lawrence; Genevieve Pepin; Cathrine Mihalopoulos
Journal:  PLoS One       Date:  2021-04-09       Impact factor: 3.240

4.  Development of an Evidence-Informed and Codesigned Model of Support for Children of Parents With a Mental Illness- "It Takes a Village" Approach.

Authors:  Melinda Goodyear; Ingrid Zechmeister-Koss; Annette Bauer; Hanna Christiansen; Martina Glatz-Grugger; Jean Lillian Paul
Journal:  Front Psychiatry       Date:  2022-01-31       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.